Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for sleep quality and hearing recovery in sudden sensorineural hearing loss
ChiCTR2400091271Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in idiopathic sudden sensorineural hearing loss (ISSNHL) (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: Correlation between LESQ sleep score reports and pure tone audiometry results. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on ChiCTR2400091271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091271.